Weather Alert
Snow is in the forecast. Consider switching to a virtual visit to receive care from home. Learn more >>
About this Video
Discover how groundbreaking research at Boston Children’s Hospital has led to a new gene therapy for sickle cell disease. Hear from Stu Orkin, MD, Dan Bauer, MD, David Williams, MD, and others as they discuss the significance of this FDA-approved treatment for the sickle cell community. Boston Children’s is proud to be recognized as a center of excellence for multiple gene therapies, including those for sickle cell disease.
Type
Conditions & Treatments
Featured Providers
Stuart Orkin, MD
Professor of Pediatrics, Harvard Medical School
Daniel Bauer, MD, PhD
Director, Gene Therapy Program; Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Donald S. Fredrickson, MD Associate Professor of Pediatrics, Harvard Medical School
Erica Esrick, MD
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Assistant Professor of Pediatrics, Harvard Medical School
Vijay Sankaran, MD, PhD
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Jan Ellen Paradise, MD Professor of Pediatrics, Harvard Medical School
Colleen Dansereau, MSN, RN, CPN
Vice President, Emerging Discoveries, Gene Therapy Operations
